Scaling Alzheimer's Care: The Case for Specialized Treatment Clinics
Journal of the American Geriatrics Society · 2025-08 · 73 (8) · 2545-2552
DOI: 10.1111/jgs.19461 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Geriatrics Society, online erschienen am 07.04.2025. Verfasst von Eric D Vidoni und 13 weiteren Autor:innen. Beteiligte Einrichtung: University of Kansas Medical Center, Kansas City, Kansas, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Ambulatory Care Facilities. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, National Institute on Aging.
Themen: Demenz
Abstract (Originalsprache)
Background
The approval of amyloid‐targeting monoclonal antibodies has transformed Alzheimer's disease (AD) treatment, shifting the field from symptomatic management to targeting the underlying pathology. These therapies require specialized care models to manage the selection, treatment, and monitoring of eligible patients.
Methods
Here, we describe the implementation of the Anti‐Amyloid Treatment Clinic (KU‐AATC) at the University of Kansas Health System, a dedicated clinic model designed to streamline access to amyloid‐clearing therapies and to provide safe, efficient patient care. We detail the KU‐AATC's structured approach, including a multidisciplinary team with advanced practice providers (APPs), leading patient evaluation and shared decision‐making, and tailored workflows to ensure timely access to treatment. We review data from the clinic's first 18 months.
Results
The KU‐AATC model demonstrates a feasible approach to managing the complex needs of amyloid‐targeting therapy for AD.
Conclusions
Our findings suggest that a specialized clinic structure can support safe, accessible, and efficient care for AD patients, potentially serving as a scalable model for healthcare systems adapting to the demands of emerging AD treatments. Expanding similar clinics may address neurologist shortages and improve equitable access to advanced therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of Kansas Medical Center, Kansas City, Kansas, USA.
- The University of Kansas Health System, Kansas City, Kansas, USA.
ORCID-Profile: Eric D Vidoni, Jaime Perales Puchalt
Förderung
- NIA NIH HHS
- National Institute on Aging
Zitieren
APA
Vidoni, E. D., Parks, A. C., Brunette, A., Kreszyn, K., Townley, R. A., Arthur, A. K., Gillen, L., Puchalt, J. P., Lewandowski, T., Mudaranthakam, D. P., Morris, J. K., Smith, T. R., Woodward, J., & Burns, J. M. (2025). Scaling Alzheimer's Care: The Case for Specialized Treatment Clinics. Journal of the American Geriatrics Society, 73(8), 2545-2552. https://doi.org/10.1111/jgs.19461
Vancouver
Vidoni ED, Parks AC, Brunette A, Kreszyn K, Townley RA, Arthur AK, et al. Scaling Alzheimer's Care: The Case for Specialized Treatment Clinics. Journal of the American Geriatrics Society. 2025;73(8):2545-2552. doi:10.1111/jgs.19461
BibTeX
@article{Vidoni2025,
author = {Vidoni, Eric D and Parks, Adam C and Brunette, Amanda and Kreszyn, Katelynn and Townley, Ryan A and Arthur, Anne K and Gillen, Lindsey and Puchalt, Jaime Perales and Lewandowski, Tina and Mudaranthakam, Dinesh P and Morris, Jill K and Smith, T Ryan and Woodward, Jennifer and Burns, Jeffrey M},
title = {Scaling Alzheimer's Care: The Case for Specialized Treatment Clinics},
journal = {Journal of the American Geriatrics Society},
year = {2025},
volume = {73},
number = {8},
pages = {2545--2552},
doi = {10.1111/jgs.19461}
}
EUVIMED